In a recent interesting paper Babaei and Stewart [1] or treatment of SMCs with different NO donors [5] demonstrated that coculture of endothelial cells (ECs) with induces VEGF expression in rat or human VSMCs, acting smooth muscle cells (SMCs) may result in the formation of at the level of transcriptional activation. Additionally, we extensive capillary-like structure. However, the effect was have recently demonstrated that VSMCs engineered to observed only when SMCs were previously transfected overexpress plasmids containing either the iNOS [5] or with vector containing the endothelial nitric oxide synthase eNOS gene [2,5] generated significantly more VEGF than (eNOS) cDNA. Such an in vitro angiogenic-like events cells transfected with control vectors. Such an enhanced were abrogated by L-NAME, a NOS inhibitor. A similar VEGF synthesis was attenuated when eNOS or iNOSangiogenic response has been observed when SMCs were transfected cells were treated with the NOS inhibitor Ltransfected with plasmids containing VEGF cDNA, the NAME, but not the inactive enantiomer, D-NAME. More 121 effect again being inhibited by L-NAME. Similarly, in a importantly, we have finally demonstrated that the conBoyden chamber model the EC migration was potently ditioned media from SMC transfected with eNOS or iNOS enhanced in the presence of SMC transfected with eNOS enhanced the proliferation of human umbilical vein endoor VEGF , and was significantly attenuated by L-NAME. thelial cells (HUVECs), the effect being abrogated by 121 Much evidence indicates that NO plays an integral role pretreatment with anti-VEGF neutralizing antibodies [5] . in VEGF signaling (see Ref.
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thelial cells (HUVECs), the effect being abrogated by 121 Much evidence indicates that NO plays an integral role pretreatment with anti-VEGF neutralizing antibodies [5] . in VEGF signaling (see Ref. [1] ). It has been convincingly In their study, Babaei and Stewart used only inhibitors demonstrated that NO may be involved in EC proliferof NOS activity and did not investigate the possibility that ation, migration, protease release and increased vascular overexpression of eNOS enhanced VEGF production [1] . permeability, the effects important for initiation of angioThus, we postulate that the direct angiogenic effect of NO genesis. Thus, the recent report by Babaei and Stewart [1] has not been yet proven. is in keeping with previous observations. The authors state
The increased morphogenic events observed by Babaei that this is the demonstration that NO exerts a direct and Stewart in the co-culture of ECs and SMCs transfected proangiogenic activity. They claim that NO generated by with VEGF expression vectors were also abolished by eNOS or by NO donors facilitate EC migration, even in the L-NAME. This observations add to the previous studies absence of growth factors [1] .
demonstrating that VEGF induces angiogenesis by enhancWe want, however, to propose another explanation for ing NO generation in endothelial cells [1] . those phenomena. A number of recent studies demonEndothelial cells are the target, not the main source of strated that NO induces VEGF synthesis in numerous cell VEGF. Microvascular endothelial cells express VEGF and types, among them SMCs ( [2] [3] [4] [5] [6] and Refs. therein). We can release some amounts of this growth factor. Machave shown that induction of inducible NOS (iNOS) [2] [3] [4] rovascular endothelial cells, like HUVECs, do not release detectable quantities of VEGF into the culture media. Interestingly, however, it has been also recently demon- in microvascular endothelial cells [7] . The detailed mecha- autocrine activity of VEGF.
